Published in Cancer on May 01, 1980
Benign hair-follicle derived tumours in the differential diagnosis of basal-cell carcinoma of the eyelids: a clinicopathological comparison. Br J Ophthalmol (1989) 1.12
Pilomatrix carcinoma presenting as an extra axial mass: clinicopathological features. Diagn Pathol (2008) 0.91
Malignant pilomatrixoma in an old english sheepdog. Can Vet J (1983) 0.89
Ectopic teeth in the orbit of a neonate. Br J Ophthalmol (1995) 0.85
Pilomatrixoma of the breast, a rare lesion simulating breast cancer: a case report. J Radiol Case Rep (2013) 0.83
Concern A patient with ulcerated calcifying epithelioma of Malherbe in the pinna: case report. Head Neck Oncol (2012) 0.81
Concurrent Pilomatrix Carcinoma and Diffuse Large B-Cell Lymphoma. Oncol Ther (2016) 0.75
Pilomatrix carcinoma: More malignant biological behavior than was considered in the past. Mol Clin Oncol (2017) 0.75
Pilomatrix carcinoma of the thoracic spine: case report and review of the literature. J Spinal Cord Med (2010) 0.75
Pilomatricoma: an unusual dermatologic neoplasm. Hawaii J Med Public Health (2012) 0.75
A Case of Old Calcifying Epithelioma Processed Symptomless over 40 Years. Case Rep Dent (2013) 0.75
Pilomatrix carcinoma of the vulva. Gynecol Oncol Rep (2015) 0.75
Complicated Giant Pilomatrixoma of the Parotid Region. J Maxillofac Oral Surg (2014) 0.75
An unusual impediment to spectacle wear: pilomatrixoma. Br J Ophthalmol (1995) 0.75
Inverted malignant pilomatricoma of the neck. Eur Arch Otorhinolaryngol (2004) 0.75
The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res (1969) 13.27
Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer (1996) 4.46
Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol (2000) 3.42
GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol (2000) 2.86
Role of the clotting system in cell-mediated hypersensitivity. I. Fibrin deposition in delayed skin reactions in man. J Exp Med (1973) 2.75
Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg (1996) 2.68
The classification of malignant melanoma and its histologic reporting. Cancer (1973) 2.67
Nonfamilial cutaneous melanoma incidence in women associated with sun exposure before 20 years of age. Pediatrics (1989) 2.61
Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome. Hum Pathol (1999) 2.50
Common and uncommon melanocytic nevi and borderline melanomas. Semin Oncol (1975) 2.36
Melanoma in children. N Engl J Med (1995) 2.35
Benign cutaneous adnexal tumors with combined folliculosebaceous, apocrine, and eccrine differentiation. Clinicopathologic and immunohistochemical study of eight cases. Am J Dermatopathol (1996) 2.30
Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial. Ann Surg (1993) 2.08
Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol (2001) 2.06
Kimura's disease and angiolymphoid hyperplasia with eosinophilia: two distinct histopathological entities. J Cutan Pathol (1987) 1.92
Automatic differentiation of melanoma from melanocytic nevi with multispectral digital dermoscopy: a feasibility study. J Am Acad Dermatol (2001) 1.91
Nonepidermal origin of malignant melanoma associated with a giant congenital nevocellular nevus. Plast Reconstr Surg (1981) 1.86
Dermal dendritic melanocytic proliferations: an update. Histopathology (2004) 1.84
Narrower margins for clinical stage I malignant melanoma. N Engl J Med (1982) 1.82
Primary melanoma of the skin: recognition and management. J Am Acad Dermatol (1980) 1.82
A new immunologic marker for human Langerhans cells. N Engl J Med (1981) 1.79
A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch Dermatol (2001) 1.77
Melasma: a clinical, light microscopic, ultrastructural, and immunofluorescence study. J Am Acad Dermatol (1981) 1.76
Basophilic leukocytes in allergic contact dermatitis. J Exp Med (1972) 1.75
Rejection of first-set skin allografts in man. the microvasculature is the critical target of the immune response. J Exp Med (1979) 1.74
Characterization of Langerhans cells by the use of monoclonal antibodies. Lab Invest (1981) 1.73
Prognostic factors for melanoma patients with lesions 0.76 - 1.69 mm in thickness. An appraisal of "thin" level IV lesions. Ann Surg (1982) 1.72
Dysplastic melanocytic nevi: a reproducible histologic definition emphasizing cellular morphology. Mod Pathol (1989) 1.71
Morphology of delayed-type hypersensitivity reactions in man. II. Ultrastructural alterations affecting the microvasculature and the tissue mast cells. Lab Invest (1976) 1.70
Morphology of delayed type hypersensitivity reactions in man. I. Quantitative description of the inflammatory response. Lab Invest (1974) 1.68
Lentigo maligna and lentigo-maligna melanoma. Am J Pathol (1969) 1.68
Squamoid eccrine ductal carcinoma. Histopathology (1997) 1.67
The clinical diagnosis, classification and histogenetic concepts of the early stages of cutaneous malignant melanomas. N Engl J Med (1971) 1.65
Studies on the cellular origin of neurothekeoma: clinical, light microscopic, immunohistochemical, and ultrastructural observations. J Am Acad Dermatol (1991) 1.59
Histopathologic diagnosis of dysplastic nevi: concordance among pathologists convened by the World Health Organization Melanoma Programme. Hum Pathol (1991) 1.54
Bullous dermatosis of hemodialysis. Ann Intern Med (1975) 1.47
Marginal zone lymphoma (low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type) of skin and subcutaneous tissue: a study of 15 patients. Am J Surg Pathol (1996) 1.45
The natural break points for primary-tumor thickness in clinical Stage I melanoma. N Engl J Med (1981) 1.45
Actin-binding protein expression in benign and malignant melanocytic proliferations. Hum Pathol (1994) 1.44
Origin of cutaneous melanoma in a congenital dysplastic nevus spilus. Arch Dermatol (1990) 1.43
Early melanoma. Histologic terms. Am J Dermatopathol (1991) 1.43
Acral lentiginous melanoma (including in situ melanoma) arising in association with naevocellular naevi. Melanoma Res (1996) 1.42
Adjuvant high-dose interferon alfa-2b in patients with high-risk melanoma. Cancer J (2000) 1.41
Topical axitinib suppresses angiogenesis pathways induced by pulsed dye laser. Br J Dermatol (2014) 1.40
A prognostic model for clinical stage I melanoma of the upper extremity. The importance of anatomic subsites in predicting recurrent disease. Ann Surg (1981) 1.38
Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51 - 3.39 mm). A conceptual model for tumor growth and metastasis. Ann Surg (1982) 1.38
Congenital melanocytic nevi of the small and garment type. Clinical, histologic, and ultrastructural studies. Hum Pathol (1973) 1.36
Bullous pemphigoid, an ultrastructural study of the inflammatory response: eosinophil, basophil and mast cell granule changes in multiple biopsies from one patient. J Invest Dermatol (1982) 1.35
Angiogenesis and tumor progression of melanoma. Quantification of vascularity in melanocytic nevi and cutaneous malignant melanoma. Lab Invest (1992) 1.34
Malignant melanoma. Prognostic significance of "microscopic satellites" in the reticular dermis and subcutaneous fat. Ann Surg (1981) 1.34
A prognostic model for clinical stage I melanoma of the lower extremity. Location on foot as independent risk factor for recurrent disease. Surgery (1981) 1.33
Risk factors for cutaneous melanoma. A practical method of recognizing predisposed individuals. JAMA (1987) 1.30
Inhibition of melanogenesis as an adjuvant strategy in the treatment of melanotic melanomas: selective review and hypothesis. Anticancer Res (1999) 1.29
Neutrophilic eccrine hidradenitis. A distinctive type of neutrophilic dermatosis associated with myelogenous leukemia and chemotherapy. Arch Dermatol (1982) 1.27
A multivariate analysis of prognostic factors for melanoma patients with lesions greater than or equal to 3.65 mm in thickness. The importance of revealing alternative Cox models. Ann Surg (1982) 1.24
Cellular neurothekeoma. A distinctive variant of neurothekeoma mimicking nevomelanocytic tumors. Am J Surg Pathol (1990) 1.23
T6 is superior to Ia (HLA-DR) as a marker for Langerhans cells and indeterminate cells in normal epidermis: a monoclonal antibody study. J Invest Dermatol (1983) 1.23
Major histocompatibility antigens and mononuclear inflammatory infiltrate in benign nevomelanocytic proliferations and malignant melanoma. J Immunol (1982) 1.21
The human sunburn reaction: histologic and biochemical studies. J Am Acad Dermatol (1981) 1.20
Cell migration and actin organization in cultured human primary, recurrent cutaneous and metastatic melanoma. Time-lapse and image analysis. Am J Pathol (1991) 1.20
T cell subsets and Langerhans cells in lichen planus: in situ characterization using monoclonal antibodies. Br J Dermatol (1981) 1.19
Degranulation of basophilic leukocytes in allergic contact dermatitis reactions in man. J Immunol (1976) 1.18
The structure of normal skin and the morphology of atopic eczema. J Invest Dermatol (1976) 1.18
Minimal deviation melanoma: a histologic variant of cutaneous malignant melanoma in its vertical growth phase. J Invest Dermatol (1983) 1.17
Morphologic and functional evidence for release of mast-cell products in bullous pemphigoid. N Engl J Med (1978) 1.16
Pigmented lesions of the conjunctiva. J Am Acad Dermatol (1998) 1.15
Detection of microscopic melanoma metastases in sentinel lymph nodes. Cancer (1999) 1.15
Self-reports of mole counts and cutaneous malignant melanoma in women: methodological issues and risk of disease. Am J Epidemiol (1988) 1.14
Desmoplastic melanoma. Histopathology (1992) 1.14
Potential mechanism of skin response to stress. Int J Dermatol (1996) 1.13
Warty (condylomatous) squamous cell carcinoma of the penis: a report of 11 cases and proposed classification of 'verruciform' penile tumors. Am J Surg Pathol (2000) 1.13
Lentigo maligna melanoma has no better prognosis than other types of melanoma. J Clin Oncol (1984) 1.12
Urticaria associated with acute viral hepatitis type B: studies of pathogenesis. Ann Intern Med (1978) 1.11
Cutaneous necrotizing venulitis in patients with cystic fibrosis. J Pediatr (1979) 1.10
Microphthalmia transcription factor expression in cutaneous benign, malignant melanocytic, and nonmelanocytic tumors. Am J Surg Pathol (2001) 1.10
Cutaneous malignant mixed tumor. Arch Dermatol (1981) 1.09
Mycosis fungoides with extracutaneous dissemination: a distinct clinicopathologic entity. Cancer (1974) 1.08
Two distinct cellular patterns in cutaneous necrotizing angiitis. J Invest Dermatol (1976) 1.07
T cell subsets in allograft rejection. In situ characterization of T cell subsets in human skin allografts by the use of monoclonal antibodies. J Immunol (1982) 1.07
Juvenile xanthogranuloma. Clinical and pathologic characterization. Arch Pathol Lab Med (1989) 1.06
Focal adhesion kinase (p125FAK) expression correlates with motility of human melanoma cell lines. J Invest Dermatol (1995) 1.06
In situ identification of T6-positive cells in normal human dermis by immunoelectron microscopy. Br J Dermatol (1983) 1.05
Acute graft-versus-host disease in recipients of bone-marrow transplants from identical twin donors. Lancet (1979) 1.04
Birthmarks with serious medical significance: nevocullular nevi, sebaceous nevi, and multiple café au lait spots. J Pediatr (1979) 1.04
Migration of human melanoma cells on hyaluronate is related to CD44 expression. J Invest Dermatol (1993) 1.04
Depletion and repopulation of epidermal dendritic cells after allogeneic bone marrow transplantation in humans. J Invest Dermatol (1985) 1.04
Malignant melanoma. Arch Pathol Lab Med (2001) 1.04
Morphology of delayed-type hypersensitivity reactions in man. J Invest Dermatol (1976) 1.03
Clear cell eccrine carcinomas of the skin. A clinicopathologic study of nine patients. Cancer (1994) 1.03
Atypical melanosis of the foot. A report of three cases in Japanese populations. Arch Dermatol (1994) 1.03
Increased thickness of pregnancy-associated melanoma. Br J Dermatol (1995) 1.02
Cutaneous malignant melanoma: prognostic guidelines for physicians and patients. CA Cancer J Clin (1982) 1.01
A prognostic model for clinical stage I melanoma of the trunk. Location near the midline is not an independent risk factor for recurrent disease. Am J Surg (1981) 1.01
Melanoma and the sun: the effect of swimsuits and a "healthy" tan on the risk of nonfamilial malignant melanoma in women. Am J Epidemiol (1991) 1.00
Outcome of patients with melanoma and histologically negative sentinel lymph nodes. Arch Surg (1999) 1.00
Encephalocraniocutaneous lipomatosis: a new neurocutaneous syndrome. Br J Dermatol (1981) 1.00
Malignant lymphoma of the skin: a clinicopathologic study of lymphoma other than mycosis fungoides. Cancer (1976) 1.00
Hereditary papulotranslucent acrokeratoderma. A new variant of familial punctate keratoderma? Arch Dermatol (1973) 1.00